Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Members should contact their plan administrator directly or request a Explanation of Benefits to determine exact GLP-1 coverage status before pursuing authorization
And while the study compared GLP-1 RAs broadly (not tirzepatide specifically), tirzepatide is a GLP-1 RA with additional GIP activity that may confer extra cardiovascular benefit
Another favorable characteristic of the DPP-4 inhibitors is their efficacy and safety profile in patients with impaired renal function
Cardiometabolic risk profile was defined as poor glycemic, blood pressure and lipid control, as well as prevalence of left ventricular diastolic dysfunction (LVDD) and carotid atherosclerosis (AS)
The groups were analyzed descriptively by demographic and clinical variables at baseline
US$ 22.54
US$ 28.23
US$ 22.74
